alanylglutamine has been researched along with Colitis, Ulcerative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, CJ; Chu, CC; Hou, YC; Pai, MH; Yeh, SL | 1 |
| Chu, CC; Hou, YC; Ko, TL; Yeh, CL; Yeh, SL | 1 |
2 other study(ies) available for alanylglutamine and Colitis, Ulcerative
| Article | Year |
|---|---|
Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Dipeptides; Disease Models, Animal; Down-Regulation; Haptoglobins; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Peroxidase; Severity of Illness Index; T-Lymphocytes, Helper-Inducer | 2012 |
Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Dipeptides; Disease Models, Animal; Down-Regulation; Gastrointestinal Agents; Haptoglobins; Inflammation Mediators; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Random Allocation; Toll-Like Receptor 4 | 2013 |